← Leaderboards
Juhua Luo
Trustees Of Indiana University
$573,102
Attributed
$573,102
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $414.6K · FY2013–22$500K$375K$250K$125K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$573,102 · 2
By mechanism
R15$414,602 · 1
R03$158,500 · 1
Top collaborators
No co-investigators on record.
Most similar at Trustees Of Indiana University
Same institution · by research overlap
- Olivier Jj Manzoni$1,545,557
Others in their field
Top investigators on “Tumor Progression”
- David Heimbrook · Leidos Biomedical Research, Inc.$115,077,246
- Timothy J Eberlein · Washington University$82,758,282
- Eric S Lander · Whitehead Institute For Biomedical Res$71,530,862
- C Kent Osborne · Baylor College Of Medicine$50,727,195
- Walter John Curran · Thomas Jefferson University$47,825,103
- Alan F Horwitz · University Of Virginia Charlottesville$42,280,666
Research focus
Tumor ProgressionMetforminMedicare ClaimPopulation BasedCancer PatientNon-Insulin-Dependent Diabetes MellitusFutureMalignant NeoplasmsNon-DiabeticPharmaceutical PreparationsWomanCancer PrognosisOralCancer TherapyCancer TypeCardiovascular DiseasesGlucoseLinkDiabetes MellitusBlood GlucoseEpidemiology StudyChronic DiseaseAntioxidantsExcretory Function
Grant awards (3)
Sodium-Glucose Cotransporter 2 (SGLT2) inhibitors and lung cancer prognosis$79,250
R03 · FY2022 · CA · contact PI
Sodium-Glucose Cotransporter 2 (SGLT2) inhibitors and lung cancer prognosis$79,250
R03 · FY2021 · CA · contact PI
Diabetes, Metformin and Breast Cancer Prognosis$414,602
R15 · FY2013 · CA · contact PI